BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 29893418)

  • 1. Clinicopathological features and outcome of type 3 gastric neuroendocrine tumours.
    Min BH; Hong M; Lee JH; Rhee PL; Sohn TS; Kim S; Kim KM; Kim JJ
    Br J Surg; 2018 Oct; 105(11):1480-1486. PubMed ID: 29893418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic submucosal dissection for foregut neuroendocrine tumors: an initial study.
    Li QL; Zhang YQ; Chen WF; Xu MD; Zhong YS; Ma LL; Qin WZ; Hu JW; Cai MY; Yao LQ; Zhou PH
    World J Gastroenterol; 2012 Oct; 18(40):5799-806. PubMed ID: 23155323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinicopathologic characteristics and prognosis of rectal neuroendocrine neoplasms].
    Liu T; Liu P; Wu T; Pan Y; Chen G; Wang P; Jiang Y; Wu Y; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1015-1019. PubMed ID: 28900992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of endoscopic and surgical resection for foregut neuroendocrine tumors.
    Jung HJ; Hong SJ; Han JP; Kim HS; Jeong GA; Cho GS; Kim HK; Ko BM; Lee MS
    J Dig Dis; 2015 Oct; 16(10):595-600. PubMed ID: 26315879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excellent prognosis following endoscopic resection of patients with rectal neuroendocrine tumors despite the frequent presence of lymphovascular invasion.
    Sekiguchi M; Sekine S; Sakamoto T; Otake Y; Nakajima T; Matsuda T; Taniguchi H; Kushima R; Ohe Y; Saito Y
    J Gastroenterol; 2015 Dec; 50(12):1184-9. PubMed ID: 25936647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between a short-term intravenous octreotide suppression test and response to antrectomy in patients with type-1 gastric neuroendocrine tumours.
    Murugesan SV; Steele IA; Dimaline R; Poston GJ; Shrotri M; Campbell F; Varro A; Pritchard DM
    Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):474-81. PubMed ID: 23249603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of gastroduodenal neuroendocrine tumors according to their WHO grade: A single-institutional retrospective analysis.
    Ryu DG; Kim SJ; Choi CW; Kang DH; Kim HW; Park SB; Nam HS; Lee SH; Hwang SH
    Medicine (Baltimore); 2022 Sep; 101(37):e30397. PubMed ID: 36123854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors of lymph node metastasis in patients with gastric neuroendocrine tumor with normal serum gastrin level.
    Jung JH; Choi KD; Koh YW; Park YS; Jung HY; Lee GH; Song HJ; Kim DH; Choi KS; Lee JH; Ahn JY; Kim MY; Bae SE; Kim JH
    Hepatogastroenterology; 2015; 62(137):207-13. PubMed ID: 25993755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric gastroenteropancreatic neuroendocrine tumor: A case report and review of the literature.
    Gaiani F; de'Angelis N; Minelli R; Kayali S; Carra MC; de'Angelis GL
    Medicine (Baltimore); 2019 Sep; 98(37):e17154. PubMed ID: 31517859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features and outcomes of gastric neuroendocrine tumors after endoscopic diagnosis and treatment: A Digestive Endoscopy Society of Tawian (DEST).
    Chung CS; Tsai CL; Chu YY; Chen KC; Lin JC; Chen BC; Sun WC; Yen HH; Chen CY; Wu IC; Kuo CH; Shih HY; Bair MJ; Wang JP; Hu WH; Yang CS; Han ML; Cheng TY; Tseng CM; Tsai MC; Hu ML; Wang HP
    Medicine (Baltimore); 2018 Sep; 97(38):e12101. PubMed ID: 30235663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is endoscopic resection appropriate for type 3 gastric neuroendocrine tumors? Retrospective multicenter study.
    Hirasawa T; Yamamoto N; Sano T
    Dig Endosc; 2021 Mar; 33(3):408-417. PubMed ID: 32578248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic efficacy analysis of endoscopic combined with serological diagnosis strategy and endoscopic in G1 and G2 gastric neuroendocrine neoplasms].
    Li WY; Liu Y; Zhang YM; Dou LZ; He S; Ke Y; Liu XD; Liu YM; Wu HR; Wang GQ
    Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):326-334. PubMed ID: 38644268
    [No Abstract]   [Full Text] [Related]  

  • 13. Gastric neuroendocrine tumors in our institutions according to the WHO 2010 classification.
    Endo S; Dousei T; Yoshikawa Y; Hatanaka N; Taniyama K; Yamauchi A; Kamiike W; Nishijima J
    Int Surg; 2012; 97(4):335-9. PubMed ID: 23294075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Consensus-Developed Morphological Re-Evaluation of 196 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Its Clinical Correlations.
    Elvebakken H; Perren A; Scoazec JY; Tang LH; Federspiel B; Klimstra DS; Vestermark LW; Ali AS; Zlobec I; Myklebust TÅ; Hjortland GO; Langer SW; Gronbaek H; Knigge U; Tiensuu Janson E; Sorbye H
    Neuroendocrinology; 2021; 111(9):883-894. PubMed ID: 33002892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of the 2017 World Health Organization Classification System for gastric neuroendocrine tumors: A single-center experience.
    Karakaş Y; Laçin Ş; Kurtulan O; Esin E; Sunar V; Sökmensüer C; Kılıçkap S; Yalçin Ş
    Turk J Gastroenterol; 2020 Feb; 31(2):91-98. PubMed ID: 32141816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-Free DNA and Clinical Characteristics in Patients with Small Intestinal or Pancreatic Neuroendocrine Tumors.
    Oversoe SK; Sorensen BS; Tabaksblat EM; Gronbaek H; Kelsen J
    Neuroendocrinology; 2022; 112(1):43-50. PubMed ID: 33461190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological characteristics and prognosis of 77 cases with type 3 gastric neuroendocrine tumours.
    Li YL; Qiu XD; Chen J; Zhang Y; Li J; Xu JM; Wang C; Qi ZR; Luo J; Tan HY
    World J Gastrointest Oncol; 2020 Dec; 12(12):1416-1427. PubMed ID: 33362912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short- and long-term outcomes of endoscopic resection of rectal neuroendocrine tumours: analyses according to the WHO 2010 classification.
    Nakamura K; Osada M; Goto A; Iwasa T; Takahashi S; Takizawa N; Akahoshi K; Ochiai T; Nakamura N; Akiho H; Itaba S; Harada N; Iju M; Tanaka M; Kubo H; Somada S; Ihara E; Oda Y; Ito T; Takayanagi R
    Scand J Gastroenterol; 2016; 51(4):448-55. PubMed ID: 26540372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple gastric G1 neuroendocrine tumors with venous and lymphatic invasion.
    Tatsuta T; Yoshimura T; Hasui K; Takasugi K; Sawaya M; Hanabata N; Shimoyama T; Kijima H; Fukuda S
    Intern Med; 2013; 52(15):1697-701. PubMed ID: 23903502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term results of endoscopic resection for type I gastric neuroendocrine tumors.
    Uygun A; Kadayifci A; Polat Z; Yilmaz K; Gunal A; Demir H; Bagci S
    J Surg Oncol; 2014 Feb; 109(2):71-4. PubMed ID: 24165913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.